Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas A. Boyd currently holds 39,539 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas A. Boyd has been a net seller of PGNX stock. They have purchased $0 and sold $1.1M worth of shares.
Thomas A. Boyd's most recent insider trade was on Jul 1, 2010, when they sold 2,675 shares at $4.44 per share.
Thomas A. Boyd serves as Executive at PROGENICS PHARMACEUTICALS INC (PGNX). They have executed 99 insider transactions totaling $1.1M over their tenure at the company.
Thomas A. Boyd holds the position of Executive at PROGENICS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Thomas A. Boyd has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas A. Boyd was on Jun 21, 2007, when they sold $48.7K worth of PGNX shares. This transaction involved 2,150 shares at $22.65 per share.
Thomas A. Boyd currently owns 39,539 shares of PROGENICS PHARMACEUTICALS INC (PGNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas A. Boyd's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas A. Boyd has 99 Form 4 filings on record as an insider at PROGENICS PHARMACEUTICALS INC.
Set alerts for Thomas A. Boyd and 40,000+ other insiders.